The National Ketamine Shortage Grinds On Causing Major Disruptions

All across the nation ketamine is on backorder Due to a staggering increase in demand for ketamine, there is a national shortage of this drug that is affecting thousands of clinics, hospitals, and providers. The major pharmaceutical companies that manufacture ketamine, Hikma Pharmaceuticals, Hospira, Pfizer, Mylan Institutional, and Par Pharmaceutical, continue to push back their …

Nasal Ketamine is Here: Spravato and the Controversy

On March 5th, 2019, the U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray. The approval is for Spravato to be used in conjunction with an oral antidepressant for the treatment of depression in adults who have failed to benefit from oral antidepressant medications. Doctors must order medication for a particular patient and pick …

treat suicidal thoughts with ketamine

Published in: Int J Mol Sci. 2018 Sep 23;19(10). pii: E2888. doi: 10.3390/ijms19102888. Ketamine may decrease suicidal thoughts The mechanism of action of ketamine in the treatment of suicidal patients involves several pathways but, first of all, the glutamatergic system seems to play a pivotal role. In fact, it has been suggested that a glutamate …

Verbal Learning and Speed of Mental Processing Improved After Ketamine Treatment

Research shows that depression successfully treated with ketamine helps learning J Psychopharmacol. 2018 Oct;32(10):1118-1126. doi: 10.1177/0269881118798614. Epub 2018 Sep 27. Summary Ketamine has proven to have rapid, robust antidepressant effects on treatment-resistant depression. However, whether repeated ketamine infusions would cause short-and long-term neurocognitive impairments was not clear. Our aims were to investigate the neurocognitive effects …

Prefrontal cortex microRNAs plays a key role in the antidepressant-like effect of ketamine in rats

Published in Exp Mol Med. 2018 Oct 29;50(10):140. doi: 10.1038/s12276-018-0164-4. Major depressive disorder Major depressive disorder is a common chronic mood disorder that results in heavy social and economic burdens. By 2020, Major depressive disorder is expected to be the second leading cause of disability worldwide. However, to date, the prospect of antidepressant treatment is …

rushing people to get ketamine infusions

Many Ketamine Clinics Do Not Adequately Screen Patients Research shows that as ketamine clinics spring up across the country, the competition for patients grows more fierce. Patients are reporting more and more that they are ushered into clinics in a very casual manner, without thorough screening. “All patients should be medically screened and evaluated psychiatrically …

Resetn Ketamine Clinic

PALM SPRINGS, Calif., June 8, 2018 /KetamineClinicsDirectory/ — One in every six U.S. adults lives with a mental illness. And one in every four Americans suffers from chronic pain. Now, some residents of Palm Springs and the Coachella Valley who suffer from chronic pain, anxiety disorders, post-traumatic stress disorder (PTSD), or treatment-resistant depression may find …